Skip to main content

Thermo Fisher Scientific Inc(TMO-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low500.00
Day High514.38
Open:511.32
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Thermo Fisher Scientific Inc

Select a category then submit the form to load news
Motley Fool
Kemnay Loads Up MercadoLibre With 1,385 Shares in Q4 Buy
StockStory
3 S&P 500 Stocks We’re Skeptical Of
ITW
Tipranks
Thermo Fisher Issues $3.8 Billion Notes for Acquisition
Tipranks
William Blair Reaffirms Their Buy Rating on Thermo Fisher (TMO)
Motley Fool
This Top Artificial Intelligence (AI) Stock Could Have More Upside in 2026
StockStory
3 Reasons to Sell TMO and 1 Stock to Buy Instead
TMO
StockStory
5 Insightful Analyst Questions From Thermo Fisher’s Q4 Earnings Call
TMO
Motley Fool
C WorldWide Group Loads Up 45,000 MercadoLibre Shares Worth $94 Million
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Thermo Fisher (TMO), Tenet Healthcare (THC)
Tipranks
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Intuitive Surgical (ISRG) and Thermo Fisher (TMO)
Tipranks
Thermo Fisher Scientific Earnings Call Highlights Steady Growth
Tipranks
Morgan Stanley Sticks to Its Buy Rating for Thermo Fisher (TMO)
Tipranks
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Phibro Animal Health (PAHC) and Unicycive Therapeutics (UNCY)
Tipranks
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO) and Mesoblast Limited (OtherMEOBF)
Tipranks
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Nurix Therapeutics (NRIX) and Thermo Fisher (TMO)
StockStory
TMO Q4 Deep Dive: Product Innovation and Strategic Acquisitions Drive Mixed Market Reaction
TMO
Motley Fool
Thermo Fisher (TMO) Q4 2025 Earnings Transcript
StockStory
Thermo Fisher (NYSE:TMO) Posts Better-Than-Expected Sales In Q4 CY2025
TMO
StockStory
Thermo Fisher (TMO) Q4 Earnings: What To Expect
TMO
StockStory
1 Mooning Stock to Own for Decades and 2 We Question
ENTG
Zacks Investment Research
The Zacks Analyst Blog Highlights Visa, Advanced Micro Devices and Thermo Fisher Scientific
The Zacks Analyst Blog Highlights Visa, Advanced Micro Devices and Thermo Fisher Scientific
Zacks Investment Research
Top Analyst Reports for Visa, AMD & Thermo Fisher
Top Analyst Reports for Visa, AMD & Thermo Fisher
Tipranks
Barclays Sticks to Its Buy Rating for Thermo Fisher (TMO)
Tipranks
Thermo Fisher Announces Planned Executive Leadership Transitions
Tipranks
Thermo Fisher (TMO) Gets a Buy from Stifel Nicolaus
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Citi Reaffirms Their Buy Rating on Thermo Fisher (TMO)
StockStory
Thermo Fisher (TMO): Buy, Sell, or Hold Post Q3 Earnings?
TMO
StockStory
3 Low-Volatility Stocks That Fall Short
TMO
MarketBeat
Sector Rotation: 2 Smart Money Moves for 2026
MarketBeat.com
StockStory
2 S&P 500 Stocks Worth Investigating and 1 We Avoid
COIN
StockStory
Q3 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks
TMO

Profile

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.